Targeted Immunomodulation

Targeted Immunomodulation is a precision therapeutic strategy within nanoparticle-based immunotechnology that selectively modulates specific components of the immune system using biologic therapeutics engineered to deliver immunomodulatory signals to defined cellular or molecular targets.

228

Publications

12.2K

Citations

1.7K

Authors

510

Institutions

Publications per year

2017–2026

179

Authors

1.7K

  1. TM
    Tarek M. Fahmy

    Yale University, United States

    4 publications · 746 citations

    4

    h-index

  2. RA
    Reza Abdi

    Brigham and Women's Hospital, United States

    3 publications · 225 citations

    4

    h-index

  3. PM
    Ping’an Ma

    Changchun Institute of Applied Chemistry, China

    2 publications · 169 citations

    3

    h-index

  4. ZG
    Zhen Gu

    University of North Carolina at Chapel Hill, United States

    3 publications · 383 citations

    3

    h-index

  5. HF
    Haibo Feng

    Southwest University, China

    3 publications · 54 citations

    3

    h-index

1–5 of 1.7K

Venues

  1. Biomaterials

    20 publications · 1.6K citations

    19

    h-index

  2. Journal of Controlled Release

    16 publications · 917 citations

    14

    h-index

  3. Nano Today

    12 publications · 283 citations

    12

    h-index

  4. ACS Nano

    9 publications · 472 citations

    9

    h-index

  5. Advanced Materials

    8 publications · 743 citations

    9

    h-index

1–5